Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Reduced Left Ventricle Ejection Fraction (<50%)”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Not applicableStudy completedNCT01900600
What this trial is testing

Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP)

Who this might be right for
Prior Acute Myocardial InfarctionEvidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l)Reduced Left Ventricle Ejection Fraction (<50%)+1 more
Virginia Commonwealth University 15
Not applicableLooking for participantsNCT05650658
What this trial is testing

Left vs Left Randomized Clinical Trial

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection FractionAV Block+4 more
Baylor College of Medicine 2,136